MRI in headache. (March 2013)

• Record Type: Journal Article
• Authors: Eller, Michael; Goadsby, Peter J
• Is Part Of: Expert review of neurotherapeutics. Volume 13:Number 3(2013)
• Page Start: 263
• Page End: 273
• Publication Date: 2013-03
• Subjects: migraine -- MRI -- trigeminal autonomic cephalalgias; Neuropharmacology -- Periodicals; 615.7805
• DOI: 10.1586/ern.13.24
• Languages: English
• ISSNs: 1473-7175

Abstract

Headaches are described as primary, where no contributing cause is found, or secondary, where a discrete lesion or other condition has triggered the phenotype. Primary headache is a common condition; migraine causes much of the morbidity in this population, at great personal and economic cost. The decision to use MRI is a common dilemma facing clinicians, particularly as primary headache phenotypes can be triggered by secondary causes. Studies demonstrate that there is no appreciable difference in the frequency of pathological and incidental findings in common headache populations compared with the general community. Imaging is therefore not routinely required where a primary headache diagnosis can be made. Clinicians must be aware of the risk of manufacturing morbidity in uncovering incidental and nonsignificant imaging changes. However, patients demonstrating 'red flags' on medical history and examination do require imaging to help exclude a secondary cause of symptoms. Other headache phenotypes, such as the trigeminal autonomic cephalalgias, also generally require MRI.